The proposed intervention has the potential to significantly transform the present situation of diabetes mellitus pharmacotherapy, particularly considering the substantial number of individuals, estimated to be around 200 million, who are in need of insulin therapy [142]. The gene discussed is INS; the disease is diabetes mellitus.